OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis)-Reference-Cited by-同舟云学术

OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis)

Published:2020-01-20 Issue:3 Volume:27 Page:227-234
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Yokoyama Osamu¹,Honda Masashi²,Yamanishi Tomonori³,Sekiguchi Yuki⁴,Fujii Kenji⁵,Nakayama Takashi⁶,Mogi Takao⁵,Kitta Takeya,Ohyama Chikara,Kambe Koichi,Tanahashi Yoshikatsu,Sasagawa Isoji,Ootani Mikinobu,Nozawa Eiyu,Saito Toshihiko,Manabe Fumio,Suzuki Yasutomo,Tomoe Hikaru,Takahashi Satoru,Kawata Nozomu,Matsushima Hisashi,Kawai Taketo,Kinjo Manami,Fukagai Takashi,Takahashi Atsuko,Nakajima Fumio,Sasaki Haruaki,Okuno Norihiko,Itoi Toshiyuki,Ishiura Yoshiyuki,Mizokami Atsushi,Matsuta Yosuke,Sawada Norifumi,Miwa Kosei,Otsuka Atsushi,Funahashi Yasuhito,Yoshida Masaki,Tobiume Motoi,Kawauchi Akihiro,Okuno Hiroshi,Nakamura Terukazu,Ninomiya Noriko,Matsushita Chie,Takenaka Atsushi,Watanabe Takeshi,Watanabe Toyohiko,Ishito Noritaka,Yamamoto Yasuyo,Ikeda Hiroshi,Seki Narihito,Kanegae Shigehiro,Suyama Kenichi,Sagiyama Kazuyuki,Tokuda Noriaki,Sakai Hideki,Nishimura Hiroaki,Kawahara Motoshi

Affiliation:

1. Department of Urology Faculty of Medical Science University of Fukui Fukui Japan

2. Department of Urology Tottori University Faculty of Medicine Tottori Japan

3. Department of Urology Dokkyo Medical University Tochigi Japan

4. Yokohama Motomachi Women’s Clinic LUNA Kanagawa Japan

5. Medicines Development Japan Development Division GlaxoSmithKline Tokyo Japan

6. Biomedical Data Sciences Department Japan Development Division GlaxoSmithKline Tokyo Japan

Funder

GlaxoSmithKline

Publisher

Wiley

Subject